T*C
发帖数: 5492 | 1 Shares of Amarin (AMRN +2.1%) return to earth since spiking higher earlier
this morning after its marketing website inadvertently circulated a report
that Amarin's AMR101, or Vascepa, will be approved. The company acknowledged
the error, saying that says no determination on AMR101 NDA has yet been
made by the FDA, adding that information on the site was outdated and should
not be relied on. | l********i
发帖数: 2503 | 2 宁可信其有。VVUS批的当日那篇文章，连药物商品名都知道了，并非空穴来风。 | k****h
发帖数: 944 | 3 AMRN PDA肯定批了，改进的鱼丸而已，不会有什么问题的。 |
|
